Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.
They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.
These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.
The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

UAE condemns terrorist plots in Morocco, supports safety measures
Mohamed bin Zayed University for Humanities receives International Quality Accreditation
UAE ministry revokes licence of private university over 'severe violations'
UAE expresses solidarity with Ghana and Ivory Coast following floods
DEWA deploys agentic AI across its digital platforms
